Reassurance of safety of letrozole and suggested approaches in controlled ovarian hyperstimulation.
Ata
Baris
B
Tulandi
Togas
T
D047072:Aromatase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D005307:Fertilization in Vitro / Q000379:methods / Q000592:standards; D006801:Humans; D000077289:Letrozole; D009570:Nitriles / Q000009:adverse effects / Q000627:therapeutic use*; D016471:Ovarian Hyperstimulation Syndrome / Q000188:drug therapy*; D010062:Ovulation Induction / Q000009:adverse effects; D027724:Reproductive Techniques, Assisted / Q000009:adverse effects; D012449:Safety; D014230:Triazoles / Q000009:adverse effects / Q000627:therapeutic use*
D047072:Aromatase Inhibitors; D009570:Nitriles; D014230:Triazoles; D000077289:Letrozole